Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Allarity Therapeutics, Inc. (ALLR)

1.24   0.12 (10.71%) 08-18 07:03
Open: 1.13 Pre. Close: 1.12
High: 1.24 Low: 1.1
Volume: 267,441 Market Cap: 12(M)
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.24 - 1.25 1.25 - 1.25
Low: 1.09 - 1.09 1.09 - 1.1
Close: 1.23 - 1.24 1.24 - 1.25

Technical analysis

as of: 2022-08-17 4:21:20 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.62     One year: 1.85
Support: Support1: 1.05    Support2: 0.88
Resistance: Resistance1: 1.38    Resistance2: 1.59
Pivot: 1.16
Moving Average: MA(5): 1.15     MA(20): 1.16
MA(100): 1.66     MA(250): 0
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 24.1     %D(3): 14.1
RSI: RSI(14): 50.7
52-week: High: 14.94  Low: 1.05
Average Vol(K): 3-Month: 206 (K)  10-Days: 73 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ALLR ] has closed below upper band by 6.3%. Bollinger Bands are 81.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 36 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 11 Aug 2022
Allarity Therapeutics (NASDAQ: ALLR): Diamond in the Rough - GlobeNewswire

Tue, 02 Aug 2022
Premarket Mover: Allarity Therapeutics Inc (ALLR) Up 14.75% - InvestorsObserver

Mon, 11 Jul 2022
Allarity Therapeutics Bolsters Its Board of Directors with Appointment of Prominent Clinical Researcher and Oncology Drug Developer, David A. Roth, M.D. - Yahoo Finance

Mon, 04 Jul 2022
An ML prediction model based on clinical parameters and automated CT scan features for COVID-19 patients | Scientific Reports - Nature.com

Fri, 27 May 2022
Avadel, PMV Pharmaceuticals top healthcare gainers; Iovance, SpringWorks lead losers' pack - Seeking Alpha

Fri, 27 May 2022
Top Penny Stocks Today: What’s Moving AVDL, BKSY, NILE, INO, & ALLR - Penny Stocks

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 9 (M)
Shares Float 8 (M)
% Held by Insiders 18.9 (%)
% Held by Institutions 3.4 (%)
Shares Short 14 (K)
Shares Short P.Month 30 (K)

Stock Financials

EPS -3.87
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.66
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -60.5
Return on Equity (ttm) -138.4
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -3.06
Qtrly Earnings Growth 0
Operating Cash Flow -18 (M)
Levered Free Cash Flow -3 (M)

Stock Valuations

PE Ratio -0.33
PEG Ratio 0
Price to Book value 0.74
Price to Sales 0
Price to Cash Flow -0.64

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.